Shares of GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) hit a new 52-week high on Wednesday after TD Cowen raised their price target on the stock from $14.00 to $24.00. TD Cowen currently has a buy rating on the stock. GeneDx traded as high as $19.60 and last traded at $19.48, with a volume […]
GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2024 Earnings Call Transcript April 29, 2024 GeneDx Holdings Corp. beats earnings expectations. Reported EPS is $-0.33, expectations were $-0.68. GeneDx Holdings Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank […]
GeneDx (NASDAQ:WGS – Get Free Report) had its price objective hoisted by equities researchers at BTIG Research from $15.00 to $19.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. BTIG Research’s target price would indicate a potential upside of 72.73% from the company’s previous […]
GeneDx (NASDAQ:WGS – Get Free Report) had its price target increased by TD Cowen from $14.00 to $24.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. TD Cowen’s target price would indicate a potential upside of 36.67% from the company’s current price. A number […]
GeneDx reports quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents by 50.75%. The company reported quarterly sales of $62.422 million which beat the analyst consensus estimate of $49.463 million by 26.2%.